CLINICAL_TRIALS
trial_result
· 2020-09-23
Clinical Trial Update: Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma [Phase 2]
Summary
A Phase 2 clinical trial reports results on the HCVIDDOXIL regimen for newly diagnosed peripheral T-cell lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-09-23